Despite proven effectiveness, vaccine uptake in high-risk groups remains low due to access barriers, misinformation, and limited trial data. In this Forum, we discuss how targeted communication, optimized vaccine formulations, inclusive trials, and real-world ... ...

请注册登录后继续浏览